Metraipolis › archive › dc_775ace079b3f

Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial — Europe PMC PMID:42344149

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42344149
DOI
10.70962/jhi.20250256
License (as archived)
solo-consultazione
Archived
2026-10-19T05:51:13.678Z
SHA-256 of the archived text
6a71e3861eb3a42b7d4b240d7b379a04adc29ca1d88d31da4dfe30f1624964da
Stable URL of this page
https://metraipolis.com/documento/dc_775ace079b3f

How to cite

Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial — Europe PMC PMID:42344149 — Europe PMC (en), https://europepmc.org/article/MED/42344149 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_775ace079b3f (Metraipolis archive dc_775ace079b3f, sha256 6a71e3861eb3a42b7d4b240d7b379a04adc29ca1d88d31da4dfe30f1624964da)
BibTeX
@misc{dc775ace079b3f,
  title = {Thalidomide for CGD-related inflammatory bowel disease: A randomized, double-blind trial — Europe PMC PMID:42344149},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42344149},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_775ace079b3f; sha256 6a71e3861eb3a42b7d4b240d7b379a04adc29ca1d88d31da4dfe30f1624964da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344149. Agents can read the archived copy with the MCP tool read_document.